Reports


United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Report 2018

  • TBI974663
  • February 15, 2018
  • United States of America
  • 107 pages
  • QY Research
                                              In this report, the United States Non-steroidal Anti-inflammatory Drugs (NSAID) market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2018 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Non-steroidal Anti-inflammatory Drugs (NSAID) in these regions, from 2013 to 2025 (forecast).

United States Non-steroidal Anti-inflammatory Drugs (NSAID) market competition by top manufacturers/players, with Non-steroidal Anti-inflammatory Drugs (NSAID) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Glaxo Smith Kline
    Johnson & Johnson
    Bayer
    Novacap
    Abbott
    Pfizer
    Geri-Care Pharmaceuticals
    Perrigo Company
    Kopran
    Merck Sharp & Dohme
    Sun Pharmaceutical Industries
    Reddy Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Aspirin
    Ibuprofen
    Naproxen
    Nabumetone
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Back Pain Treatment
    Osteoarthritis Treatment
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 

Table of Contents

United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Report 2018
1 Non-steroidal Anti-inflammatory Drugs (NSAID) Overview
    1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)
    1.2 Classification of Non-steroidal Anti-inflammatory Drugs (NSAID) by Product Category
        1.2.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (Sales Volume) Comparison by Type (2013-2025)
        1.2.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
        1.2.3 Aspirin
        1.2.4 Ibuprofen
        1.2.5 Naproxen
        1.2.6 Nabumetone
        1.2.7 Other
    1.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Application/End Users
        1.3.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
        1.3.2 Back Pain Treatment
        1.3.3 Osteoarthritis Treatment
        1.3.4 Other
    1.4 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Region
        1.4.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 The West Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2013-2025)
        1.4.3 Southwest Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2013-2025)
        1.4.4 The Middle Atlantic Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2013-2025)
        1.4.5 New England Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2013-2025)
        1.4.6 The South Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2013-2025)
        1.4.7 The Midwest Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2013-2025)
    1.5 United States Market Size (Value and Volume) of Non-steroidal Anti-inflammatory Drugs (NSAID) (2013-2025)
        1.5.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2013-2025)
        1.5.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2013-2025)

2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Players/Suppliers
    2.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share of Key Players/Suppliers (2013-2018)
    2.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Share by Players/Suppliers (2013-2018)
    2.3 United States ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form

 

Related Reports